CSLLY Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 15:57):

Stats
Today's Volume	59 529.00
Average Volume	32 643.00
Market Cap	84.01B
Last Dividend	$0.645 ( 2023-09-08 )
Next Dividend	$0 ( N/A )
P/E	34.22
ATR14	$0.136 (0.16%)

Volume Correlation

Long: -0.05 (neutral)

Short: 0.95 (very strong)

Signal:(48.201) Expect same movement, but be aware

CSL Limited Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CSL Limited Correlation - Currency/Commodity

-0.03
( neutral )

0.54
( weak )

0.00
( neutral )

0.63
( weak )

-0.10
( neutral )

0.08
( neutral )

CSL Limited Financials

Annual	2023
Revenue:	$13.17B
Gross Profit:	$6.71B (50.92 %)
EPS:	$2.27

Q2	2023
Revenue:	$8.02B
Gross Profit:	$4.11B (51.29 %)
EPS:	$1.960

Q4	2023
Revenue:	$6.00B
Gross Profit:	$2.67B (44.45 %)
EPS:	$0.620

Q3	2023
Revenue:	$4.58B
Gross Profit:	$2.23B (48.65 %)
EPS:	$0.880

Financial Reports:

No articles found.

CSL Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.590 (N/A)	$0 (N/A)	$0.535 (N/A)	$0 (N/A)	$0.645 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

CSL Limited Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.49 - Stable (9.72%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.158	2010-03-10
Last Dividend	$0.645	2023-09-08
Next Dividend	$0	N/A
Payout Date	2023-09-09
Next Payout Date	N/A
# dividends	28	--
Total Paid Out	$10.42	--
Avg. Dividend % Per Year	0.00%	--
Score	3.97	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.49
Div. Directional Score	8.98	--

Next Divdend (Est)
(2024-07-01)

$0.671 Estimate 7.55 %

Dividend Stability

0.30 Poor

Dividend Score

3.97

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
WYGPY	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
MRRTY	Ex Dividend Junior	2023-09-08	Sporadic	0.00%
CRZBY	Ex Dividend Junior	2023-06-01	Sporadic	0.00%
STBI	Ex Dividend Knight	2023-08-14	Quarterly	0.00%
HLTOY	Ex Dividend Knight	2023-07-07	Annually	0.00%
BAYRY	Ex Dividend Junior	2023-05-02	Annually	0.00%
OPHLF	Ex Dividend Knight	2023-09-28	Annually	0.00%
DYNE	No Dividend Player	2023-07-26	Sporadic	0.00%
TMRAY	Ex Dividend Knight	2023-05-01	Annually	0.00%
JBSAY	Ex Dividend Junior	2023-06-29	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.177	1.500	6.45	9.68	[0 - 0.5]
returnOnAssetsTTM	0.122	1.200	5.92	7.10	[0 - 0.3]
returnOnEquityTTM	0.253	1.500	8.30	10.00	[0.1 - 1]
payoutRatioTTM	0.429	-1.000	5.71	-5.71	[0 - 1]
currentRatioTTM	2.15	0.800	4.25	3.40	[1 - 3]
quickRatioTTM	0.971	0.800	9.00	7.20	[0.8 - 2.5]
cashRatioTTM	0.216	1.500	9.91	10.00	[0.2 - 2]
debtRatioTTM	0.282	-1.500	5.30	-7.95	[0 - 0.6]
interestCoverageTTM	7.34	1.000	8.39	8.39	[3 - 30]
operatingCashFlowPerShareTTM	4.63	2.00	8.46	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.816	2.00	9.09	10.00	[0 - 20]
debtEquityRatioTTM	0.612	-1.500	7.55	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.493	1.000	5.11	5.11	[0.2 - 0.8]
operatingProfitMarginTTM	0.244	1.000	7.12	7.12	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.425	1.000	8.75	8.75	[0.2 - 2]
assetTurnoverTTM	0.690	0.800	8.73	6.99	[0.5 - 2]
Total Score				12.47

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	19.44	1.000	8.14	0	[1 - 100]
returnOnEquityTTM	0.253	2.50	8.91	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.816	2.00	9.39	10.00	[0 - 30]
dividendYielPercentageTTM	1.348	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.63	2.00	8.46	10.00	[0 - 30]
payoutRatioTTM	0.429	1.500	5.71	-5.71	[0 - 1]
pegRatioTTM	-3.59	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.174	1.000	8.16	0	[0.1 - 0.5]
Total Score				5.49

CSL Limited

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.